Background/objective: The end-systolic pressurevolume relation (ESPVR) is a useful method to assess left ventricular contractility during stress providing prognostic information above and beyond regional wall motion. The aim of the study was to assess the prognostic value of ESPVR in patients with diabetes mellitus having negative dobutamine stress echocardiography by wall motion criteria. Design: We enrolled 233 patients with diabetes mellitus (140 males; mean age 67 (SD 9); mean ejection fraction 52 (SD 10)) having negative dobutamine (up to 40 mg/kg/min with atropine 1 mg) stress echocardiography. In all, ESPVR was determined at rest and at the peak of stress as the ratio of peak systolic pressure and end-systolic volume (SP/ESV) index. ...
The aim of this study was to compare the prognostic value of pharmacologic stress echocardiography i...
AimsDiastolic dysfunction in acute myocardial infarction (MI) reflect severe damage and adverse outc...
OBJECTIVE — Coronary artery disease (CAD) is a leading cause of mortality and morbidity in diabetic ...
The additive prognostic value of end-systolic pressure-volume relation in patients with diabetes mel...
ObjectivesThe aim of this prospective, multicenter, observational study was to compare the prognosti...
Aims An abnormal left ventricular volume response during dobutamine echocardiography identified pati...
OBJECTIVE — The aim of this study was to assess the incremental value of dobutamine stress echocardi...
OBJECTIVE - To determine the incremental prognostic value of dobutamine stress echocardiography (DSE...
OBJECTIVEdTo determine the incremental prognostic value of dobutamine stress echocar-diography (DSE)...
Objectives: Aim of this prospective, multicenter, observational study was to assess the prognostic v...
BACKGROUND: To determine if patients without dobutamine induced left ventricular wall motion abnorma...
ObjectivesWe sought to determine the prognostic value of dobutamine stress echocardiography (DSE) fo...
OBJECTIVE - This study sought to determine whether stress echocardiography using exercise (when feas...
Background. To determine if patients without dobutamine induced left ventricular wall motion abnorma...
Aims: To compare the prognostic value of pharmacologic stress echocardiography in diabetic and nondi...
The aim of this study was to compare the prognostic value of pharmacologic stress echocardiography i...
AimsDiastolic dysfunction in acute myocardial infarction (MI) reflect severe damage and adverse outc...
OBJECTIVE — Coronary artery disease (CAD) is a leading cause of mortality and morbidity in diabetic ...
The additive prognostic value of end-systolic pressure-volume relation in patients with diabetes mel...
ObjectivesThe aim of this prospective, multicenter, observational study was to compare the prognosti...
Aims An abnormal left ventricular volume response during dobutamine echocardiography identified pati...
OBJECTIVE — The aim of this study was to assess the incremental value of dobutamine stress echocardi...
OBJECTIVE - To determine the incremental prognostic value of dobutamine stress echocardiography (DSE...
OBJECTIVEdTo determine the incremental prognostic value of dobutamine stress echocar-diography (DSE)...
Objectives: Aim of this prospective, multicenter, observational study was to assess the prognostic v...
BACKGROUND: To determine if patients without dobutamine induced left ventricular wall motion abnorma...
ObjectivesWe sought to determine the prognostic value of dobutamine stress echocardiography (DSE) fo...
OBJECTIVE - This study sought to determine whether stress echocardiography using exercise (when feas...
Background. To determine if patients without dobutamine induced left ventricular wall motion abnorma...
Aims: To compare the prognostic value of pharmacologic stress echocardiography in diabetic and nondi...
The aim of this study was to compare the prognostic value of pharmacologic stress echocardiography i...
AimsDiastolic dysfunction in acute myocardial infarction (MI) reflect severe damage and adverse outc...
OBJECTIVE — Coronary artery disease (CAD) is a leading cause of mortality and morbidity in diabetic ...